These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21747624)

  • 21. Supraciliary wrinkles and botulinum toxin A.
    Ghalamkarpour F; Robati RM; Aryanejad F; Toossi P
    Clin Exp Dermatol; 2010 Jun; 35(4):388-91. PubMed ID: 19874314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
    Pribitkin EA; Greco TM; Goode RL; Keane WM
    Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):321-6. PubMed ID: 9076240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum toxin A in the treatment of wrinkles in the upper third of the face].
    Gassia V
    Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S299-305. PubMed ID: 19931689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE; Easthope SE
    Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead?
    Kim YJ; Lim OK; Choi WJ
    Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 3D Morphometrical Evaluation of Brow Position After Standardized Botulinum Toxin A Treatment of the Forehead and Glabella.
    Schlager S; Kostunov J; Henn D; Stark BG; Iblher N
    Aesthet Surg J; 2019 Apr; 39(5):553-564. PubMed ID: 30124769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical effect of botulinum toxin on pigmentation.
    Erdil D; Manav V; Türk CB; Kara Polat A; Koku Aksu AE
    Int J Dermatol; 2023 Feb; 62(2):250-256. PubMed ID: 36468824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of neubotulinumtoxinA for the treatment of forehead horizontal lines in Asians - A clinical, prospective, interventional, split-face study.
    Sy JJ; Wu R; Wan J; Kim SB; Yi KH
    Skin Res Technol; 2024 Apr; 30(4):e13644. PubMed ID: 38533764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic Evaluation of Skin Displacement by the Frontalis Muscle Contraction Using Three-Dimensional Skin Displacement Vector Analysis.
    Kwon IJ; Lee W; Moon HJ; Lee SE
    Yonsei Med J; 2023 Jul; 64(7):440-447. PubMed ID: 37365738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cosmetic use of botulinum toxin type B in the upper face.
    Sadick NS
    Clin Dermatol; 2004; 22(1):29-33. PubMed ID: 15158542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A; Carruthers J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontal Alopecia after Repeated Botulinum Toxin Type A Injections for Forehead Wrinkles: An Underestimated Entity?
    Di Pietro A; Piraccini BM
    Skin Appendage Disord; 2016 Sep; 2(1-2):67-69. PubMed ID: 27843928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective and randomized study comparing ultrasound-guided real time injection to conventional blind injection of botulinum neurotoxin for glabellar wrinkles.
    Wu Y; Zhang Y; Li H; Lin J; Ye H; Chen X; Tang K
    J Cosmet Dermatol; 2024 Sep; 23(9):2867-2875. PubMed ID: 38726847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin dosage template for frontal wrinkle effacement.
    Sternick I; Pitanguy I
    Aesthet Surg J; 2011 Sep; 31(7):814-20. PubMed ID: 21908813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ophthalmic adverse events following facial injections of botulinum toxin A: A systemic literature review.
    Skorochod R; Nesher R; Nesher G; Gronovich Y
    J Cosmet Dermatol; 2021 Aug; 20(8):2409-2413. PubMed ID: 34097809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study.
    Keen M; Blitzer A; Aviv J; Binder W; Prystowsky J; Smith H; Brin M
    Plast Reconstr Surg; 1994 Jul; 94(1):94-9. PubMed ID: 8016257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel OnabotulinumtoxinA Treatment Technique to Obtain Predictable Outcomes in Eyebrow Position and Shape.
    Angelo-Khattar M
    Clin Cosmet Investig Dermatol; 2020; 13():781-787. PubMed ID: 33149650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.